Invesco Ltd. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 185 filers reported holding SAGE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$7,179,786
+347.9%
661,122
+672.9%
0.00%
Q1 2024$1,603,001
+15.5%
85,539
+33.5%
0.00%
Q4 2023$1,388,093
+1.8%
64,056
-3.3%
0.00%
Q3 2023$1,363,322
-73.6%
66,245
-39.8%
0.00%
-100.0%
Q2 2023$5,172,388
+109.3%
110,004
+86.8%
0.00%0.0%
Q1 2023$2,471,444
-25.8%
58,900
-32.5%
0.00%0.0%
Q4 2022$3,329,622
-0.3%
87,300
+2.3%
0.00%0.0%
Q3 2022$3,341,000
+18.6%
85,308
-2.2%
0.00%0.0%
Q2 2022$2,818,000
-20.1%
87,253
-18.1%
0.00%0.0%
Q1 2022$3,528,000
+42.5%
106,593
+83.2%
0.00%0.0%
Q4 2021$2,475,000
-55.8%
58,185
-54.0%
0.00%0.0%
Q3 2021$5,604,000
-82.3%
126,477
-77.3%
0.00%
-87.5%
Q2 2021$31,598,000
-71.6%
556,204
-62.6%
0.01%
-73.3%
Q1 2021$111,363,000
-13.3%
1,487,817
+0.2%
0.03%
-18.9%
Q4 2020$128,433,000
+40.6%
1,484,593
-0.7%
0.04%
+19.4%
Q3 2020$91,367,000
+26.4%
1,494,886
-14.0%
0.03%
+19.2%
Q2 2020$72,282,000
+42.8%
1,738,408
-1.4%
0.03%
+23.8%
Q1 2020$50,622,000
-65.3%
1,762,611
-12.7%
0.02%
-53.3%
Q4 2019$145,792,000
-43.3%
2,019,556
+10.3%
0.04%
-32.8%
Q3 2019$256,983,000
-30.6%
1,831,793
-9.4%
0.07%
-29.5%
Q2 2019$370,201,000
+242.2%
2,021,964
+197.2%
0.10%
+163.9%
Q1 2019$108,193,000
+77.8%
680,244
+7.1%
0.04%
+56.5%
Q4 2018$60,841,000
-25.4%
635,149
+10.0%
0.02%
-11.5%
Q3 2018$81,571,000
+53.1%
577,494
+69.7%
0.03%
+44.4%
Q2 2018$53,277,000
+127.9%
340,361
+134.5%
0.02%
+100.0%
Q1 2018$23,382,000
+196.0%
145,170
+202.7%
0.01%
+200.0%
Q4 2017$7,900,000
+16.3%
47,959
-56.0%
0.00%0.0%
Q3 2017$6,790,000
-22.4%
108,993
-0.8%
0.00%0.0%
Q2 2017$8,746,000
-13.3%
109,821
-22.6%
0.00%0.0%
Q1 2017$10,087,000
+31.4%
141,937
-5.6%
0.00%0.0%
Q4 2016$7,675,000
+66.3%
150,309
+50.0%
0.00%
+50.0%
Q3 2016$4,616,000
+262.9%
100,231
+152.6%
0.00%
+100.0%
Q1 2016$1,272,000
+25340.0%
39,687
+53531.1%
0.00%
Q2 2015$5,000740.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders